PRA Health Sciences (PRAH) Reports In-Line Q3 EPS

November 2, 2016 4:15 PM EDT
Get Alerts PRAH Hot Sheet
Trade PRAH Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

PRA Health Sciences (NASDAQ: PRAH) reported Q3 EPS of $0.64, in-line with the analyst estimate of $0.64. Revenue for the quarter came in at $399.8 million versus the consensus estimate of $394.87 million.


PRA Health Sciences sees FY2016 EPS of $2.45-$2.48, versus the consensus of $2.47.

For earnings history and earnings-related data on PRA Health Sciences (PRAH) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment